It's the clearest view yet of RFK Jr.'s investments and potential conflicts of interest as he works to become HHS secretary.

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of ...

The roundtable, convened by Sen. Bernie Sanders (I-Vt.) clearly served as a prep session ahead of the confirmation hearings ...

Tthe Senate Finance Committee hearing on the nomination will be on Jan. 29, per an announcement obtained by STAT. The Senate ...

The Trump administration has put a freeze on many federal health agency communications with the public through at least the ...

After a double mastectomy to avoid breast cancer, Oceana Callum learned that her implants put her at risk of lymphoma. She ...

A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer ...

As the former president of the Navajo Nation, I support changes to make the federal dietary guidelines emphasize plant-based ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.